These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7365284)

  • 1. Gene composition of high-yielding influenza vaccine strains obtained by recombination.
    Baez M; Palese P; Kilbourne ED
    J Infect Dis; 1980 Mar; 141(3):362-5. PubMed ID: 7365284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaquing characteristics of influenza A virus recombinants of defined genetic composition. Brief report.
    Oxford JS; Callow KA; Corcoran T; Beare AS
    Arch Virol; 1982; 74(2-3):227-32. PubMed ID: 7165510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence.
    Oxford JS; McGeoch DJ; Schild GC; Beare AS
    Nature; 1978 Jun; 273(5665):778-9. PubMed ID: 661986
    [No Abstract]   [Full Text] [Related]  

  • 4. ts P1 and P3 genes are responsible for satisfactory level of attenuation of ts-1A2 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus.
    Massicot JG; Murphy BR; van Wyke K; Huang KY; Chanock RM
    Virology; 1980 Oct; 106(1):187-90. PubMed ID: 6893373
    [No Abstract]   [Full Text] [Related]  

  • 5. High reproduction capacity of recombinants between H3N2 human influenza and fowl plague viruses is due to the gene coding for M proteins.
    Klimov A; Ghendon Y; Závadová H; Broucek J; Medvedeva T
    Acta Virol; 1983 Sep; 27(5):434-8. PubMed ID: 6139948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein.
    Lubeck MD; Schulman JL; Palese P
    J Virol; 1978 Dec; 28(3):710-6. PubMed ID: 731792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses.
    Xu X; Kilbourne ED; Hall HE; Cox NJ
    J Infect Dis; 1994 Dec; 170(6):1432-8. PubMed ID: 7995982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies on biological properties and genome composition of influenza virus recombinants.
    Podchernyaeva RYa ; Blinova VK; Sokolova NN; Farashyan VR; Zhdanov VM; Irzhanov SD; Lvov DK; Ghendon YuZ
    Acta Virol; 1983 May; 27(3):209-16. PubMed ID: 6138981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants.
    Ghendon YZ; Polezhaev FI; Lisovskaya KV; Medvedeva TE; Alexandrova GI; Klimov AI
    Infect Immun; 1984 Jun; 44(3):730-3. PubMed ID: 6724694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and identification of influenza virus recombinants of defined genetic composition.
    Schulman JL; Palese P
    J Virol; 1976 Oct; 20(1):248-54. PubMed ID: 978791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutations in the genes coding for hemagglutinin and neuraminidase in cold-adapted variants of the influenza virus A/Leningrad/134/57 (H2N2)].
    Medvedeva TE; Kudriavtseva VK; Zhikhareva IV; Romashkina VV; Aleksandrova GI; Klimov AI
    Vopr Virusol; 1991; 36(2):96-100. PubMed ID: 1882532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of recombinants derived from autochthonous influenza virus type A strains.
    Mihail A; Popa LM; Petrescu A; Dumitrescu SM
    Virologie; 1981; 32(3):225-9. PubMed ID: 7303494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of pathogenicity of fowl plague virus by recombination with other influenza A viruses nonpathogenic for fowl: nonexculsive dependence of pathogenicity on hemagglutinin and neuraminidase of the virus.
    Rott R; Orlich M; Scholtissek C
    J Virol; 1976 Jul; 19(1):54-60. PubMed ID: 985888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors that cause a change in the antigenic structure of of the influenza virus hemagglutinin].
    Markushin SG; Ginzburg VP; Khaĭder AM; Iarosh VV; Ivas'ko EA; Klimov AI
    Vopr Virusol; 1992; 37(4):196-9. PubMed ID: 1281944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetic analysis of a cold-adapted donor attenuation strain for a pediatric liver influenza vaccine, of recombinants based on it and of isolates from vaccinated children].
    Gendon IuZ; Klimov AI; Lisovskaia KV; Aleksandrova GI; Medvedeva TI
    Vopr Virusol; 1984; 29(1):22-8. PubMed ID: 6710977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on some genetic properties of antigenic recombinants of influenza viruses.
    Podchernyaeva RYa ; Döhner L; Herrmann RM; Blinova VK; Ivanova VT
    Acta Virol; 1982 Jul; 26(4):227-33. PubMed ID: 6127929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus.
    Orlich M; Gottwald H; Rott R
    Virology; 1994 Oct; 204(1):462-5. PubMed ID: 8091680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditions for production of thermosensitive attenuated influenza virus recombinants.
    Polezhaev FI; Garmashova LM; Polyakov YM; Golubev DB; Aleksandrova GI
    Acta Virol; 1978 Jul; 22(4):263-9. PubMed ID: 29464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.
    Naito T; Mori K; Ushirogawa H; Takizawa N; Nobusawa E; Odagiri T; Tashiro M; Ohniwa RL; Nagata K; Saito M
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Derivation of high-yielding influenza A virus recombinants for vaccine production (author's transl)].
    Higashihara M; Suzuki Y; Saito Y; Igarashi Y; Yoshioka I
    Uirusu; 1978 Jun; 28(1):46-8. PubMed ID: 695332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.